Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

NCT02310581 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Post-operative Pain

Interventions

DRUG: Buprenorphine Sublingual Spray
DRUG: Placebo

Sponsor

INSYS Therapeutics Inc